TRENDING
Connect With DiversityInc
TRENDING
Novartis and The Max Foundation Transform Pioneering Cancer Access Program for People in Lower-Income Countries
The Max Foundation to lead program for patients and oversee supply chain management; Novartis to contribute funding and product donation.
Novartis Foundation Launches Initiative to Tackle Hypertension in Low-Income Urban Communities
Novartis Foundation and its partners, including Intel Corporation, the NCD Alliance, city governments and local partners, announce the launch of Better Hearts Better Cities.
Achieving Gender Balance in Senior Leadership
Leaders from Novartis, Sodexo, Johnson & Johnson and Marriott International provide insights into critical factors that enabled their companies to make progress in gender balance in senior leadership.
Novartis: Together We Can End Malaria for Good
Meet some of the faces behind the Novartis Malaria Initiative and listen to their stories.
Novartis Foundation Welcomes Vas Narasimhan to Board of Trustees
"We have much to gain from Dr. Narasimhan's leadership in both global health and in drug development at Novartis," said Head of the Novartis Foundation Ann Aerts.
Novartis Invests in Next Generation Therapies to Reduce Cardiovascular Risk
Novartis enters into an exclusive option agreement with Ionis and Akcea to license two investigational treatments expected to reduce cardiovascular risk in patients living with elevated levels of lipoprotein.
Novartis Study: SEG101 Antibody Reduces Frequency of Sickle Cell Pain
The results of the sickle cell study are being published in The New England Journal of Medicine.
Novartis Acquires Selexys Pharmaceuticals Corporation, SelG1 Antibody for Pain Reduction in Sickle Cell Disease
Acquisition complements and broadens Novartis' hematology pipeline and underscores commitment to improving care for patients with high unmet needs.
Experimental Treatment Clears Malaria Infections in Novartis Small Clinical Study
Compound offers a potential tool for fighting drug-resistant malaria parasites.
Novartis Dialogue to Explore Solutions to Rise of Chronic Diseases in Developing World
The event will take place November 29 on the Novartis Campus in Basel, Switzerland and will also be webcast.
Novartis' New Orbis Flying Eye Hospital Helps Fight Blindness in China
Meet Novartis' flying hospital that brings training to local eye care professionals in under-resourced communities
Novel Novartis Malaria Compound Shows Potential to be Effective Against Infections Resistant to Antimalarial Drugs
Each year, malaria kills nearly half a million people, most of whom are children.
DIVERSITYINC TOP 50
PRODUCTS & SERVICES
© Copyright 2018 — DiversityInc All Rights Reserved.